Introduction {#s1}
============

The MAPK family of proteins is a ubiquitous signaling element in eukaryotes, and is essential to the function of a wide variety of cellular behaviors, from the regulation of differentiation and proliferation to stress responses and more ([@bib15]); this diversity of functions has been made possible by the evolutionary expansion of the MAPK repertoire ([@bib13]; [@bib42]). For the expansion of the MAPK signaling module to have been feasible, it needed to be amenable to forming new kinase-substrate regulatory links, while at the same time having the capacity to avoid unwanted crosstalk. However, it still remains unclear what information is sufficient to create an entirely new set of regulatory interactions. One way to understand how potentially large numbers of novel regulatory links can be established is by developing a scalable method to create such links ourselves ([@bib21]).

What are the core components necessary for the formation of a new -- functional -- kinase-substrate interaction? Following the association of the kinase and substrate, the amino acids in the immediate vicinity of the phosphorylated residue -- together making up the 'phospho-motif' -- help to dictate whether the substrate is phosphorylated by the kinase ([@bib46]; [@bib31]). However, it is the site that is phosphorylated -- rather than the kinase itself -- that mediates the functional outcome of kinase regulation. In particular, the phosphorylated phospho-motif can be recognized by a regulatory protein bearing a phospho-motif binding domain and control protein localization or degradation among many other effects ([@bib65]; [@bib9]).

Even before the kinase has a chance to interact with the phospho-motif, the two proteins must be colocalized ([@bib74]). Residues apart from the kinase active site are frequently responsible for recognizing a substrate; indeed, several studies have sought to modify or replace these residues in a variety of kinases to redirect them to new -- but still related -- targets ([@bib69]; [@bib77]; [@bib24]). Adaptor proteins, such as synthetic scaffolds, have also been used to steer a kinase towards a particular native substrate ([@bib54]; [@bib76]; [@bib28]; [@bib26]). Regulation of a modified native substrate by a kinase can also be rescued using a pair of completely heterologous interaction domains ([@bib79]). These studies show that by controlling the colocalization of a kinase with a native -- or closely related -- substrate allows the functional regulation of that target. Taking it a step further, two groups have recently used native MAPK-interacting motifs -- 'docking domains' -- to allow several types of MAPKs in mammalian cells and yeast to regulate the nuclear localization of fluorescent reporters ([@bib56]; [@bib20]). Although it is generally accepted that docking domains primarily control colocalization ([@bib66]), several studies suggest that binding may also serve to allosterically regulate the MAPK ([@bib16]; [@bib27]; [@bib82]; [@bib73]; [@bib9]). As such, the precise role of these interactions remains unclear. Regardless, the question of how completely new and orthogonal regulatory relationships are created remains.

Like the signaling modules that have been expanded in natural systems, engineered genetic circuits also rely on components that are amenable to rewiring. The creation of novel transcription factors has been successful in a large part because the necessary functional characteristics have been identified. Importantly, these characteristics can be embodied in distinct modular DNA and protein domains, such as promoters, transcriptional-regulation domains, and DNA-binding domains -- these domains can then be mixed and matched to yield the desired connectivity and regulation ([@bib35]; [@bib70]; [@bib37]; [@bib81]; [@bib34]). Although hurdles to creating large genetic circuits remain ([@bib12]; [@bib14]), these parts have allowed scientists to construct and interrogate more complex engineered and naturally occurring genetic systems ([@bib55]; [@bib23]). Unfortunately, our understanding of how to assemble modular post-translational signaling proteins lags behind. At the same time, recent work with engineered modular receptors expressed on T-cells has shown the considerable power of the ability to rationally design even relatively simple post-translational signaling systems ([@bib78]; [@bib61]; [@bib48]).

Targeting a kinase to a new substrate is an essential step towards creating modular kinase signaling systems. As discussed above, Regot *et al*. and Durandau *et al.* have described an approach wherein a kinase-specific docking domain can be used to direct a particular kinase to a new substrate---a powerful tool for interrogating natural kinase signaling systems ([@bib56]; [@bib20]). However, the number of naturally occurring kinase-substrate docking interactions inherently limits the scalability of the approach. For example, a given kinase 'module' cannot be reused in parallel signaling pathways, because it would not be able to distinguish between downstream targets in one pathway versus another. To overcome this limitation, it would be useful to be able to tease apart the 'targeting' module of the kinase from the 'enzymatic' module---and likewise, the 'targeting' and 'effector' modules of the substrate. If these functions can be defined as separable parts, the enzymatic module of a kinase would be available for reuse in orthogonal pathways, just by pairing it with unique targeting domains.

We have used simple, single-function modular protein domains to explicitly test the requirements for allowing a MAPK to regulate an arbitrary substrate protein. We utilized modular interaction domains to co-localize Fus3 -- the terminal MAPK of the mating pathway of the yeast *Saccharomyces cerevisiae* -- with a substrate of interest. To link phosphorylation of the substrate to a meaningful regulation event we utilized phosphorylation-activated ubiquitination-based signaling motifs---phosphodegrons. We re-targeted Fus3 to regulate several disparate proteins to determine the flexibility of the substrate design rules. Likewise, to determine whether this approach generalizes to other MAPKs, we retargeted a constitutively active version of the mammalian MAPK, ERK2, to functionally regulate a fluorescent reporter in yeast.

We explored the effect that synthetically implemented post-translational regulatory connections could have on the signaling of an endogenous kinase cascade in yeast. Our results demonstrate that these new connections can be used to alter the natural signaling behaviors, damping signal amplification and even yielding concentration-based band-pass filtering. Taken together, in this paper, we define a modular set of scalable components that can be utilized to rewire MAPKs to regulate proteins through ubiquitination. Attempting to rationally design new kinase-substrate regulatory links not only sheds light on the natural processes, but also serves as the foundation for the construction of synthetic kinase signaling pathways, and with them the control of cell behaviors in biomedical or biotechnological applications.

Results {#s2}
=======

Targeting a MAPK to phosphorylate and regulate a novel substrate {#s2-1}
----------------------------------------------------------------

To test whether a direct interaction -- along with a functional phospho-motif -- can render an arbitrary protein a substrate for a MAPK, we used the yeast MAPK Fus3 to target and regulate a fluorescent reporter protein. Fus3 is easily triggered using the yeast mating pheromone, α-factor. α-factor signals to the central MAPK kinase cascade via a surface-associated receptor; signaling through the pathway activates Fus3, which in turn mediates signaling to a myriad of downstream effectors, directly regulating protein function and gene expression ([Figure 1A](#fig1){ref-type="fig"}) ([@bib3]).10.7554/eLife.15200.003Figure 1.Rewiring the mating cascade MAPK, Fus3, to regulate the degradation of YFP.(**A**) The core components of the yeast mating cascade. The yeast mating factor -- α-factor -- triggers the sequential activation of the kinases Ste11 and Ste7 (rounded gray rectangles) followed by the MAPK, Fus3 (yellow). Arrows with red circles denote phosphorylation-mediated regulation. All three kinases are organized on the scaffold Ste5 (also gray). Among other effectors, Fus3 activates the transcription factor Ste12 (rounded gray box). (**B**) Fus3 targeted regulation of YFP (green). The colocalization was controlled by the addition of the mPDZ domain to YFP and a PDZ ligand to Fus3 (light blue). Degradation was mediated by the addition of a phosphodegron derived from the transcription factor Tec1 (purple). Upon activation of the mating pathway, Fus3 phosphorylates the phosphodegron fused to YFP, resulting in the recruitment of an E3 ubiquitin ligase and the ubiquitination and subsequent degradation of YFP. (**C**) Cells bearing the modified Fus3 and either the fully functional system, a reporter construct with an inactivated phosphodegron, a Fus3 with its kinase activity knocked out or an unmatched interaction domain (an SH3 domain instead of mPDZ) were grown to log phase and induced with 10 μM α-factor (blue histograms) or un-induced (gray histograms). Data shown are from 3 hrs post-induction. The vertical dashed black lines on the histograms represent medians of treated populations and solid black lines represent medians of untreated populations. In all figures, the fluorescence has been normalized to the cell size (see [Figure 1---figure supplement 1](#fig1s1){ref-type="fig"}). Full time-course experiments appear in the supplement to [Figure 2](#fig2){ref-type="fig"}.**DOI:** [http://dx.doi.org/10.7554/eLife.15200.003](10.7554/eLife.15200.003)10.7554/eLife.15200.004Figure 1---figure supplement 1.Reducing the variability of single-cell fluorescence by accounting for cell-to-cell variation in cell size.In yeast constitutively expressing a single-copy fluorescent protein inserted in the genome, fluorescence (FL1-A) is strongly correlated with cell size (approximated by FSC-A)---shown by R^2^ values. This is true in both cells that are untreated (top left) or treated with 10 µM α-factor (bottom left). The effect is likely due to the way that flow cytometers measure fluorescence, where cells with the same concentration of fluorescent protein -- but with different volumes -- will have different levels of fluorescence. For example, smaller cells that have just divided will have a lower fluorescence value than larger cells that are just about to divide. Normalizing by cells size -- dividing FL1-A by FSC-A -- reduces the coefficient of variation (CV) of the fluorescent signal by \~67% or \~41% in untreated or treated cells, respectively (graphs on right).**DOI:** [http://dx.doi.org/10.7554/eLife.15200.004](10.7554/eLife.15200.004)10.7554/eLife.15200.005Figure 1---figure supplement 2.Western Analyses of degradation assays.The representative western blots above show results from degradation assays on a test strain with the entirely functional system described in [Figure 1](#fig1){ref-type="fig"} and a control strain that has a non-functional phosphodegron. We observe that upon treatment with α-factor, the test strain has a significantly fainter band as compared to the untreated lane, whereas the control strain does not. This is consistent with our flow cytometry observations. We also observe that when cells are treated with MG132, a proteasome inhibitor, the alpha-factor triggered degradation in the test strain is prevented, implying that the degradation we observe is indeed due to the proteasome as hypothesized.**DOI:** [http://dx.doi.org/10.7554/eLife.15200.005](10.7554/eLife.15200.005)10.7554/eLife.15200.006Figure 1---figure supplement 3.Swapping interaction domains between kinase and substrate.Population histograms and medians of YFP fluorescence signal normalized by cell size for yeast strains that have either a Fus3 kinase fused to a PDZ ligand and YFP fused to a PDZ domain (right) or Fus3 kinase fused to a PDZ domain and YFP fused to a PDZ ligand. These strains were diluted down from saturated overnights and were grown for 5 hrs to log phase and then cytometry reads were performed after 2, 3 and 4 hrs post induction with α-factor. The dashed black lines represent the median fluorescence at 4 hrs and the solid black lines are the media fluorescence at 0 hr.**DOI:** [http://dx.doi.org/10.7554/eLife.15200.006](10.7554/eLife.15200.006)10.7554/eLife.15200.007Figure 1---figure supplement 4.Fusing interaction domain to the native copy of the kinase.Population histograms (bottom) and corresponding medians (top) of YFP fluorescence signal normalized by cell size for yeast strains where the native copy of the kinase is fused to a PDZ ligand. The left most panel describes a strain with just the YFP substrate, the middle one represents a strain where the endogenous copy of Fus3 had an interaction domain fused to it but the YFP substrate has a non-functional degron and the rightmost panel describes a strain that has both an interaction domain on the Fus3 and a functional degron on the YFP substrate. These strains were diluted down from saturated overnights and were grown for 5 hrs to log phase and then cytometry reads were performed at 15 min intervals post induction with α-factor.**DOI:** [http://dx.doi.org/10.7554/eLife.15200.007](10.7554/eLife.15200.007)

Given the important role ubiquitin-based degradation plays in signaling ([@bib32]; [@bib71]), we decided to use a phosphodegron as the regulated phospho-motif. Upon phosphorylation, the phosphodegron interacts with a specialized F-box protein -- Cdc4 -- to recruit the E3 ubiquitin ligase machinery (the SCF complex), which then marks the substrate for degradation by covalently attaching a poly-ubiquitin chain ([Figure 1A](#fig1){ref-type="fig"}) ([@bib68]). A phosphodegron has the added benefit of making a functional phosphorylation event easy to observe: if the substrate protein is a fluorescent reporter, such as YFP, phosphorylation and subsequent ubiquitination is followed by a decrease in YFP fluorescence. Thus, this approach is amenable to high-throughput measurements in a way that changes in localization may not be.

To start, we wanted to use a phosphodegron that was proven to be both functional and compatible with Fus3. The transcription factor Tec1 fulfills these criteria, as it has been shown to be both a substrate for Fus3 and Cdc4 ([@bib17]; [@bib2])---thus, we chose a region of Tec1 that encompassed several residues up and downstream of the Cdc4 consensus sequence (37 residues, total) ([@bib49]; [@bib53]). Also, since Cdc4 primarily acts in the nucleus, we added a nuclear localization signal derived from SV40 large T-antigen to the N-terminus of the protein ([@bib10]; [@bib33]). To complete our synthetic substrate, we needed to control its interaction with an engineered kinase. To this end, we added the mPDZ domain to the YFP-degron fusion, a modular protein interaction domain that has been used in a variety of different contexts ([@bib19]; [@bib47]; [@bib63]). To target Fus3 to the new substrate, we fused the complementary interaction domain, the PDZ ligand, to its C-terminus ([Figure 1B](#fig1){ref-type="fig"}). As in all the following experiments, these constructs were integrated as a single copy into the haploid yeast genome. Moreover, since we were only concerned with whether our modified Fus3 construct was able to functionally target our new YFP substrate -- and not the behavior of other effectors downstream of the mating pathway -- we did not remove the native *FUS3* gene---thus, our modified Fus3 construct operated in parallel with the native Fus3.

Following the induction of the mating pathway with 10 µM α-factor, we measured the YFP fluorescence of the cells using flow cytometry---to account for variation caused by cell-to-cell differences in cell size, we normalized the fluorescent signal by cell size ([Figure 1---figure supplement 1](#fig1s1){ref-type="fig"}). We observed a \~3.7-fold drop in the yeast strain containing both the Fus3-mPDZ ligand fusion and our new YFP-degron-mPDZ construct ([Figure 1C](#fig1){ref-type="fig"}). On the other hand, the drop in fluorescence was not observed when the phospho-acceptor residues in the degron (two threonine residues) were changed to methionine and alanine ([@bib2]), when the catalytic site of the targeted kinase was inactivated with a K42R mutation ([@bib22]), or when the interaction domain fused to YFP was changed to an SH3 domain. The latter suggests that the Tec1 degron is not able to directly recruit Fus3 to the YFP construct on its own. Finally, we also found that the drop in YFP fusion protein level was sensitive to the presence of the proteasomal inhibitor MG132, strongly suggesting that the construct was indeed being tagged and actively degraded ([Figure 1---figure supplement 2](#fig1s2){ref-type="fig"}).

We also explored whether our rewiring approach was sensitive to which protein --- the substrate or the kinase --- the respective interaction domains were fused to. We built yeast strains in which the interaction domains were flipped---with the Fus3 kinase fused to the mPDZ domain and the YFP-degron fusion linked to a PDZ ligand. Following induction of the mating pathway with α-factor, we measured the YFP fluorescence of the cells using flow cytometry and observed qualitatively similar substrate degradation. However, the fold change observed three hours post induction for the swapped domains was approximately half that of the original orientation ([Figure 1---figure supplement 3](#fig1s3){ref-type="fig"}). This is likely due to the fusions affecting either protein expression or sterically interfering with the function of one of the involved enzymes. While these results demonstrate that this retargeting approach is largely modular, they also suggest that other characteristics of the fusions -- such as how they affect translation or protein folding -- may not be.

We also asked whether endogenous Fus3 could be re-targeted in the fashion described above. We found that by inserting the sequence encoding the PDZ ligand downstream of the native copy of the *FUS3* gene in the yeast genome, the native kinase could just as efficiently cause the degradation of the YFP substrate ([Figure 1---figure supplement 4](#fig1s4){ref-type="fig"}). These results -- along with those discussed above -- imply that an interaction domain and a phospho-motif are necessary and sufficient to target the regulation of a native signal transduction cascade to a substrate of choice.

Expanding the repertoire of interaction domains {#s2-2}
-----------------------------------------------

To determine how general our targeting approach is, we exchanged the mPDZ/PDZ ligand pair for unrelated pairs of modular protein interaction domains, both naturally derived and synthetic. We built variants of our Fus3-substrate pair with the naturally occurring SH3 domain or the synthetic SYNZIP domain ([Figure 2A](#fig2){ref-type="fig"}) ([@bib19]; [@bib72]). In both cases we observed significant reporter degradation, \~10.1-fold in the case of SH3 and \~4.7-fold for SYNZIP domains versus a control with a degron in which the two threonine residues in the Cdc4 binding site had been switched to a methionine or alanine ([Figures 2B](#fig2){ref-type="fig"} and [Figure 2---figure supplement 1](#fig2s1){ref-type="fig"}). These results confirm the flexible nature of the interactions that enable a productive kinase-substrate interaction.10.7554/eLife.15200.008Figure 2.Demonstrating the flexibility and scalability of the system by varying interaction domains.(**A**) Variants of the different complementary interaction domains used. The constitutive interaction domains mPDZ, SH3 and SYNZIP are shown on the left; the ABA inducible ABI-PYL interaction domains appear on the right. (**B**) Comparison of YFP signal normalized by cell size from constructs bearing the indicated interaction domains along with either a functional (blue histograms) or non-functional (gray histograms) phosphodegron in yeast treated with 10 μM α-factor as in [Figure 1C](#fig1){ref-type="fig"}. The vertical dashed black lines on the histograms represent the medians of the populations with functional degrons whereas the solid black lines represent the median of the populations with non-functional degrons. (**C**) Median fluorescence -- shaded regions cover the interquartile range -- and population histograms of the YFP signal normalized to cell size from cells expressing the ABA inducible ABI-PYL interaction domains fused to Fus3 and YFP, respectively for a range of ABA concentrations. The raw time-course data corresponding to these endpoint observations can be found in [Figure 2---figure supplement 1](#fig2s1){ref-type="fig"}.**DOI:** [http://dx.doi.org/10.7554/eLife.15200.008](10.7554/eLife.15200.008)10.7554/eLife.15200.009Figure 2---figure supplement 1.Time course characterization of different interaction domain variants post induction with α-factor.In this plot each subplot is labeled with the name of the interaction domain pair that was used to target the MAPK Fus3 to degrade a YFP reporter in the yeast strain. These yeast strains were grown up to log phase from saturated cultures for 5 hrs and then induced with 10 μM α-factor at time 0 to activate the kinase. The dashed lines are uninduced controls. In the case of the ABI-PYL strain two additional induction conditions were assayed, namely with ABA (100 μM) and with ABA and α-factor. For these cultures the medium used to grow the yeast up to log phase had ABA in it. The fluorescence of these cultures was then assayed at regular intervals using flow cytometry. Raw data for two replicates performed on different days under identical conditions is shown.**DOI:** [http://dx.doi.org/10.7554/eLife.15200.009](10.7554/eLife.15200.009)

We further tested our approach using a pair of inducible interaction domains derived from a plant hormone-sensing pathway. The association of the protein domains PYL and ABI can be controlled using the small-molecule plant hormone abscisic acid (ABA) ([Figure 2A](#fig2){ref-type="fig"}, right side) ([@bib39]). When we fused these domains to Fus3 and our YFP-phosphodegron reporter, we observed a change in the fluorescent signal only when the concentration of ABA was 1 μM or higher ([Figure 2C](#fig2){ref-type="fig"}). These results provide additional evidence both that the kinase and substrate are indifferent as to the nature of their interaction, and that the targeting of the kinase to the substrate directly triggers the observed degradation, as the decrease in the YFP signal is correlated with ABA dose. However, it is important to note that the identity of the interaction domain fused to the YFP-phosphodegron target influenced the steady-state fluorescence of the reporter ([Figure 2---figure supplement 1](#fig2s1){ref-type="fig"}). Thus, even interaction domains with similar affinities may not have equivalent behaviors when used inside of cells.

We next investigated whether synthetic interaction domains enable multiple MAPKs to target independent substrates in parallel and in an orthogonal manner. We targeted one copy of Fus3 to an mCherry-phosphodegron reporter using a constitutive mPDZ-PDZ ligand interaction and a second copy of Fus3 to a YFP-phosphodegron reporter via the ABA inducible ABI-PYL interaction ([Figure 3A](#fig3){ref-type="fig"}). In the presence of α-factor alone only the mCherry signal was reduced, while the YFP value remained unchanged. Only when both α-factor and ABA were added, did we see a drop in the YFP signal ([Figure 3B and C](#fig3){ref-type="fig"}). From this perspective, the two Fus3 variants are analogous to orthologous MAPKs, with each targeting its own substrate.10.7554/eLife.15200.010Figure 3.Targeting of orthogonal substrates.(**A**) Cells expressed two distinct forms of modified Fus3 and used either a constitutive interaction domain (left) or the ABA inducible domains (right) to target mCherry or YFP, respectively. (**B**) Population histograms of mCherry (left) and YFP (right) fluorescence normalized by cell size for cells under the indicated conditions---i.e. untreated, treated with 10 μM α-factor, treated with 100 μM ABA or both. The solid vertical black lines on the histograms represent the medians of the untreated populations and the dashed black lines represent the medians of the treated populations.**DOI:** [http://dx.doi.org/10.7554/eLife.15200.010](10.7554/eLife.15200.010)10.7554/eLife.15200.011Figure 3---figure supplement 1.Competition between two Fus3 MAPKS with different interaction domains for MAPKK Ste7.Population histograms of YFP fluorescence signal normalized by cell size for yeast strains that have either a single copy of Fus3 targeted to a YFP substrate via an ABA dependent PYL interaction domain (top) or two copies of Fus3 one with a PDZ ligand and another with a PYL domain (bottom). These strains were diluted down from saturated overnights and were grown for 5 hrs to log phase with and without ABA and then cytometry reads were performed after 2 hrs post-induction with α-factor. Each plot corresponds to a specific induction condition, with the solid black lines indicating the median of the untreated controls and the dashed black lines indicating the median of that particular treatment. The magnitude of log differences between treated and untreated medians for each treatment is displayed the treatment label.**DOI:** [http://dx.doi.org/10.7554/eLife.15200.011](10.7554/eLife.15200.011)10.7554/eLife.15200.012Figure 3---figure supplement 2.Competition between mCherry and GFP when targeted by the same Fus3.Population histograms of mCherry (left) and YFP (right) fluorescence signal normalized by cell size for yeast strains that have either a single YFP substrate targeted by Fus3 via a PDZ interaction (top) or two substrates, YFP and mCherry, both of which are targeted by Fus3 via a PDZ interaction (bottom). These strains were diluted down from saturated overnights and were grown for 5 hrs to log phase. Measurement of fluorescence was performed with flow cytometry 2 hrs post-induction with α-factor. The treated populations are depicted as blue histograms and the untreated as gray histograms. The solid black lines indicating the median of the untreated controls and the dashed black lines indicating the median of α-factor treated cells. The magnitude of log differences between the median values of the treated and untreated samples are indicated on each plot.**DOI:** [http://dx.doi.org/10.7554/eLife.15200.012](10.7554/eLife.15200.012)

However, we noticed that when there were two parallel MAPK-substrate systems in the same cell the net fold change of the ABA-sensitive YFP-phosphodegron reporter was moderately reduced compared to when it was present on its own---from \~2.15 to \~1.85 fold. We tested whether this decrease in efficiency was due to competition---either between the two copies of Fus3 for the pool of the activated upstream MAPK kinase, Ste7, or between the substrates for the ubiquitination/degradation machinery. To examine this question we constructed strains that expressed our standard system -- one kinase targeting one substrate -- and added either a competing copy of Fus3 or a competing substrate. In both experiments we observed a diminished response in YFP degradation in the presence of the competitor ([Figure 3---figure supplements 1](#fig3s1){ref-type="fig"} and [2](#fig3s2){ref-type="fig"}). Thus, it is likely that a confluence of factors -- both saturation points as well as the less efficient ABA-induced interaction -- contribute to the different levels of degradation observed for the mCherry and YFP reporters in this dual-targeting system.

The parallel synthetic kinases mimic the behaviors of a natural pair of yeast MAPKs, Fus3 and Kss1. Fus3 and Kss1 share many of the same targets, but also have distinct substrates, presumably as a result of the specialization of their preferences for related docking domains ([@bib58]). Likewise, the engineered system described above also retains the native targeting of Fus3, but uses distinct heterologous protein interaction domains to recognize unique targets.

Exploration of alternative phosphodegrons {#s2-3}
-----------------------------------------

The ability to modulate the dynamics of MAPK-dependent degradation would be useful for reprogramming cell behaviors. We explored two strategies to modulate the degradation dynamics. First, we varied the number of phosphodegrons fused to the protein ([Figure 4A](#fig4){ref-type="fig"}). As we increased the number of phosphodegrons from one to three, we observed a concurrent increase in the rate of degradation of the reporter; adding more than three phosphodegrons to the reporter did not seem to affect the rate of degradation further ([Figure 4B](#fig4){ref-type="fig"}). In addition to changing the degradation dynamics, increasing the number of phosphodegrons also decreased the steady state expression of the reporter, possibly by multiplying the weaker interactions of the un-phosphorylated degron(s) with the degradation machinery ([Figure 4---figure supplement 1](#fig4s1){ref-type="fig"}).10.7554/eLife.15200.013Figure 4.Modulating regulation by altering the number and sequence of phosphodegrons.(**A**) We varied either the phosphodegron number (left) or the sequence (right)---differing residues are red, the phosphorylated residue is highlighted in blue. (**B**) Time-course data of strains induced with 10 μM α-factor and expressing Fus3 targeting YFP reporters with one to five phosphodegrons. The fluorescence of each strain was normalized to cell size and then to its initial fluorescence. Data normalized only to cell size can be found in [Figure 3---figure supplement 1](#fig3s1){ref-type="fig"}. (**C**) Fus3 targeting of YFP substrates with the indicated phosphodegron sequence variants. As in **B**), the fluorescence of each strain is normalized to cell size and then against its initial fluorescence. Data normalized only to cell size can be found in [Figure 3---figure supplement 2](#fig3s2){ref-type="fig"}. The curves indicate the median values, while the shaded regions cover the interquartile range.**DOI:** [http://dx.doi.org/10.7554/eLife.15200.013](10.7554/eLife.15200.013)10.7554/eLife.15200.014Figure 4---figure supplement 1.Time course data of reporter variants with different numbers of phosphodegrons normalized by cell size.Each subplot in this plot is a replicate of the experiment performed on different days under identical conditions. Each yeast strain assayed was diluted from a saturated culture, grown for 5 hours to reach log phase growth and then induced with 10 μM α-factor at time 0 to activate the kinase. The fluorescence of these cultures was then assayed at regular intervals using flow cytometry. Data for each variant is depicted in a different color with dark blue being one degron and light blue being five adjacent degrons. Solid lines indicate the median value, while shaded regions indicate the interquartile range.**DOI:** [http://dx.doi.org/10.7554/eLife.15200.014](10.7554/eLife.15200.014)10.7554/eLife.15200.015Figure 4---figure supplement 2.Time course data of reporter variants with different degron sequences normalized by cell size.Each yeast strain assayed was grown up to log phase from saturated cultures for 5 hrs and then induced with 10 μM α-factor at time 0 to activate the kinase. The fluorescence of these cultures was then assayed at regular intervals using flow cytometry. Solid lines indicate the median value, while shaded regions indicate the interquartile range.**DOI:** [http://dx.doi.org/10.7554/eLife.15200.015](10.7554/eLife.15200.015)

We found that altering the amino acid sequence of the phosphodegron itself also changed the dynamics of degradation. We constructed two additional variants of the phosphodegron motif that more closely mimicked the amino acid sequence of the published 'consensus motif' for the WD40 domain of Cdc4 ([Figure 3A](#fig3){ref-type="fig"}) ([@bib49]; [@bib53]). The sequences of the two variants only differ at one site --- two residues N-terminal of the phosphorylated threonine --- where the Cdc4 consensus leucine was changed to a proline, an amino acid that is supposed to be preferred by Fus3 ([@bib46]). Both variants had similar behaviors, with a similarly decreased rate of degradation relative to the phosphodegron derived from Tec1. ([Figure 4C](#fig4){ref-type="fig"}). These results suggest that phosphodegron design is flexible, and with more study it may become feasible to rationally tune their degradation dynamics. Moreover, the number of phosphodegrons is not limited to those found in nature. Taken together, these results demonstrate that our approach is applicable to several different phosphodegrons, and lays out a framework for how phosphodegrons may be used to alter degradation dynamics of a protein of interest.

Retargeting the mammalian MAPK ERK2 {#s2-4}
-----------------------------------

We next swapped out the kinase module to test whether other MAPKs are also amenable to rewiring in the same manner. We focused on the human MAPK, ERK2---a widely studied kinase implicated in several pathologies, which has also been previously studied in the context of yeast ([@bib52]). Native ERK2 has been shown to regulate protein stability via phosphodegrons; for example, a phosphodegron found in the protein MKP1 is targeted by ERK2 and subsequently tagged by the ubiquitin machinery and degraded ([@bib40]). Our engineered substrate consisted of a 64 residue region surrounding the phosphodegron of MKP-1 fused to a YFP reporter. Rather than port the entire ERK2 signaling cascade into yeast, we used a constitutively active version of the MAPK created by fusing the upstream MAPK kinase -- MEK1 -- to ERK2 ([@bib60]). To enable the kinase-substrate interaction we fused the mPDZ domain and PDZ ligand to the substrate and MAPK, respectively ([Figure 5A](#fig5){ref-type="fig"}). We also included a construct missing the heterologous targeting domains to make sure that targeting was not simply due to direct interactions mediated by sequence elements surrounding the phosphodegron. Since the strains constitutively expressed both the engineered kinase and target, we measured the steady-state YFP fluorescence via flow cytometry. In strains with the active kinase targeting the functional YFP reporter, fluorescence did not rise above background levels ([Figure 5B](#fig5){ref-type="fig"})---suggesting that the substrate is actively targeted, phosphorylated and then degraded. Fluorescence was significantly higher in control strains where the interaction domain, the phosphodegron or both were missing or inactivated ([Figure 5B](#fig5){ref-type="fig"}). These results indicate that the interaction domains and the phosphodegron are necessary and sufficient for retargeting the regulation of ERK2. Importantly, these results also strongly suggest that this rewiring approach is potentially applicable to a wide range of MAPKs.10.7554/eLife.15200.016Figure 5.Retargeting the mammalian MAPK, ERK2.(**A**) As with Fus3, the human MAPK, ERK2, was targeted to a YFP reporter (green) via an interaction between the mPDZ domain and the PDZ ligand. A phosphodegron (yellow) fused to the YFP reporter was derived from the mammalian MKP-1. ERK2 was rendered constitutively active by fusing it to a constitutively active form of MEK1 (purple). (**B**) Population histograms of YFP fluorescence normalized by cell size of yeast strains in log phase growth with active ERK2 targeted to YFP with a functional phosphodegron (blue histogram). Controls strains with an inactive phosphodegron fused to YFP and/or an untargeted version of the kinase were also tested (gray histograms). The solid vertical black lines on the histograms represent the medians of the first histogram -- the untargeted kinase paired with the non-functional degron -- and the dashed black lines represent the medians of each subsequent population.**DOI:** [http://dx.doi.org/10.7554/eLife.15200.016](10.7554/eLife.15200.016)

Modifying MAPK cascade signal processing {#s2-5}
----------------------------------------

Thus far, we have described the retargeting of MAPKs to synthetic targets such as fluorescent proteins, which double as the readout for kinase activity. Next, we asked whether MAPKs could be targeted to arbitrary endogenous substrates and -- more specifically -- whether this approach can be used to modify the response of an existing signaling pathway. To answer these questions, we targeted Fus3 to up- and downstream elements in the yeast mating cascade, including the kinase Ste7, the scaffold protein Ste5, and the transcription factor Ste12. We built a total of six yeast strains containing the synthetic kinase-substrate pairs. Three of these strains constitutively expressed Fus3 with a PDZ interaction domain, while the other three expressed a version of Fus3 with a non-matching interaction domain. All of the strains included one of the mating cascade proteins -- Ste5, Ste7 or Ste12 -- fused to a complementary interaction domain and the Tec1 phosphodegron. The interaction domain and phosphodegron were inserted into the native genomic locus of the protein of interest. The Fus1 gene, whose expression is activated by the mating pathway upon induction with α-factor, was fused to YFP to provide an independent readout for pathway activation.

We chose these specific target proteins because their regulation by Fus3 results in interesting regulatory topologies. Specifically, Fus3-mediated degradation of Ste7 and Ste5 are examples of negative feedback loops, while the degradation of Ste12 results in an incoherent feed-forward loop ([Figure 6A--C](#fig6){ref-type="fig"}). Such regulatory links can be used to fundamentally alter the signal processing properties of native pathways ([@bib1]; [@bib4]). Of note, this is the first time that purely post-translational feedback loops have been used to re-engineer signaling.10.7554/eLife.15200.017Figure 6.Implementation of negative feedback and feed-forward signaling topologies using a rewired MAPK.(**A**--**C**) Plots and schematics that depict the relationship between the α-factor input and the YFP reporter for yeast strains with synthetic post-translational negative feedback or feed-forward loops. Fus3 (yellow) was rewired to target (**A**) the scaffold Ste5, (**B**) the kinase Ste7 or (**C**) the transcription factor Ste12 (all depicted in light blue)--in each case, the endogenous copies of these proteins were modified by inserting a phosphodegron and a complementary interaction domain at their C-terminus. Plots of the median fluorescence of the YFP reporter -- under the control of the mating-specific pFUS1 promoter -- normalized to cell size for increasing concentrations of α-factor. Data from control strains with an untargeted kinase -- and thus no feedback/feed-forward control -- are shown in dark blue. Points indicate the median values at each α-factor concentration, while the vertical bars cover the interquartile range of the data. The data from both the no feedback and feedback conditions were used to determine the parameter values used with the formula: $A + ~B\frac{{\lbrack\alpha\rbrack}^{n}}{1 + ~C{\lbrack\alpha\rbrack}^{n}}$ -- where $C$ was fixed between the two data sets. $n$ and $\lbrack\alpha$\] are the hill coefficient and the α-factor concentration, respectively. Fits are plotted as dashed lines. Time courses of the same strains treated with 10 µM α-factor are shown in [Figure 6---figure supplement 1](#fig6s1){ref-type="fig"}.**DOI:** [http://dx.doi.org/10.7554/eLife.15200.017](10.7554/eLife.15200.017)10.7554/eLife.15200.018Figure 6---figure supplement 1.Time course charecterization of Negative feedback topologies.Timecourse data of YFP fluorescence for populations of yeast cells where the MAPK Fus3 is targeted to phosphorylate and cause the degradation of Ste12, Ste5 or Ste7 (from left to right) after they were induced with 10 μM α-factor at time 0. The blue solid lines depict medians of strains that had a negative feedback topology described in the corresponding cartoon and the gray solid lines are medians for control strains that had a non-frunctional phosphodegrons. The blue and gray ribbons describe the interquartile range.**DOI:** [http://dx.doi.org/10.7554/eLife.15200.018](10.7554/eLife.15200.018)

To determine the impact of negative feedback, we measured the fluorescence output of the pathway following induction with varying levels of α-factor. Relative to the untargeted controls, the negative feedback through Ste5 or Ste7 reduced the maximal pathway activation in those backgrounds by \~60% and \~45%, respectively. The apparent Hill coefficients (n~H~) were also moderately changed with negative feedback compared to the untargeted kinase controls---when Ste5 was the target, n~H~ increased from 1.5 to 1.9, while when Ste7 was negatively regulated n~H~ remained 1.6 ([Figure 6A and B](#fig6){ref-type="fig"}). These values are qualitatively consistent with but slightly higher than the sensitivities reported previously for a system with negative feedback realized through transcription and recruitment of a phosphatase in the yeast mating cascade ([@bib4]).

The increase in pathway sensitivity observed for negative feedback applied to Ste5 is surprising ([@bib36]). However, the response of a scaffolded signaling cascade is highly sensitive to the concentration of the scaffold protein---with a reduction of the scaffold concentration resulting in an increase in the sensitivity of the cascade ([@bib38]). Although a more detailed analysis is required, this observation suggests a potential explanation for the observed increase in the apparent Hill coefficient. However, we also note different fusion proteins are required for each experiment and that these protein modifications alone can result in changes of the pathway sensitivity---e.g. by changing the concentrations of pathway components ([@bib52]). For example, the non-feedback controls in the three experiments shown in [Figure 6](#fig6){ref-type="fig"} have apparent Hill coefficients of n~H~ =1.5, 1.6 and 2.1.

In the incoherent feed-forward loop -- created by having Fus3 both activate and inhibit the transcription factor Ste12 -- we find that the inhibitory connection dominates at all levels of induction resulting in a complete elimination of the downstream response ([Figure 6C](#fig6){ref-type="fig"} and [Figure 6---figure supplement 1](#fig6s1){ref-type="fig"}). However, as we will show next, more interesting behaviors are possible in a slightly more complex incoherent feed-forward loop.

Hybrid regulatory schemes that occur at the level of both transcription and translation are often observed in nature and further enrich the available behaviors in the design of engineered biological circuits ([@bib80]; [@bib45]). By putting the YFP-phosphodegron-mPDZ domain fusion protein under the control of the mating pathway-controllable promoter -- pFUS1 -- we created a simple incoherent feed-forward circuit regulated at the level of both transcription and translation. Such a 'type 3' incoherent feed-forward loop design can produce pulses and other behaviors, depending on the design parameters ([@bib41]). A phenomenological model of a hybrid incoherent feed-forward loop is included in Appendix 1. We performed time-course experiments over a range of α-factor concentrations ([Figure 7B](#fig7){ref-type="fig"} and [Figure 7---figure supplement 1](#fig7s1){ref-type="fig"}). In cells containing the feed-forward loop the fluorescent signal initially increased sharply as the α-factor concentration was increased from 0.1 μM to \~1 μM---however, induction with concentrations of α-factor higher than 1 μM resulted in decreasing levels of YFP fluorescence. The incoherent feed-forward loop thus created a concentration-based band-pass filter for the α-factor input. In a control where the phosphodegron fused to YFP was broken we observe the normal signal amplification behavior of the mating cascade ([Figure 7A](#fig7){ref-type="fig"})---thus, it is the targeted regulation of YFP by Fus3 that caused the band-pass-like behavior.10.7554/eLife.15200.019Figure 7.Conversion of a native amplifier to a band-pass filter.(**A**, **B**) The relationship between the α-factor input and YFP expression -- driven by the mating pathway-specific promoter pFUS1 -- for strains without and with a synthetic post-translational incoherent feed-forward loop. Induction of the mating pathway activated a modified Fus3 (yellow) that indirectly up-regulates the expression of a YFP reporter (green) fused to a phosphodegron. An interaction between the Fus3 and the YFP-degron reporter was enabled via complementary interaction domains. In one case (**A**) the phosphodegron was mutated and inactive, while in the other (**B**) it was fully functional. The points indicate the median YFP signal -- normalized by cell size and then to the untreated condition -- in yeast strains in log phase growth treated with the indicated concentration of α-factor. The error bars depict the interquartile range of the population data. Dashed lines are fits to the equation $A + B\frac{{\lbrack\alpha\rbrack}^{n}}{1 + C{\lbrack\alpha\rbrack}^{n}}\frac{1 + E\lbrack\alpha\rbrack}{1 + D\lbrack\alpha\rbrack}$ -- model derivation and fitting are described in more detail in Appendix 1. Time-course data is shown in [Figure 7---figure supplement 1](#fig7s1){ref-type="fig"}.**DOI:** [http://dx.doi.org/10.7554/eLife.15200.019](10.7554/eLife.15200.019)10.7554/eLife.15200.020Figure 7---figure supplement 1.Time course of dose response behavior to α-factor induction of yeast strains with (top row) and without (bottom row) the mating cascade modified with an incoherent feed forward loop.Each yeast strain assayed was grown up to log phase from saturated cultures for 5 hrs and then induced with a range of different α-factor concentrations. The fluorescence of these cultures was then assayed at regular intervals --- indicated above each graph --- using flow cytometry. Median data (solid blue line) with the interquartile range (blue ribbon) of the population for two replicates performed on different days under identical conditions is shown.**DOI:** [http://dx.doi.org/10.7554/eLife.15200.020](10.7554/eLife.15200.020)

Taken together, these results demonstrate that re-targeted kinases can be used to modulate the behavior of signaling cascades through variety of circuit designs, including negative feedback and incoherent feed-forward loops. The data also highlight the utility of using this rewiring approach to study the effects of kinase-directed ubiquitination-based regulation, which occur extensively in nature ([@bib71]; [@bib5]) and adds to the available tools for the study of this pervasive mode of signaling ([@bib64]; [@bib44]; [@bib11]; [@bib51]).

Discussion {#s3}
==========

Here we have demonstrated that MAPK-directed ubiquitin-based signaling can be rewired to regulate a protein of choice. The addition of sets of two modular components is sufficient to rewire a MAPK to regulate any protein of interest---a complementary set of protein interaction domains and a phosphodegron. Natively, MAPKs are co-localized with their substrates via an interaction between the docking peptide of a substrate and a set of residues on the surface of the MAPK; it has been hypothesized that this interaction may be necessary to catalytically unlock the kinase ([@bib16]; [@bib27]; [@bib82]; [@bib73]). Our results suggest that while these domains may have some allosteric properties, simply co-localizing an active MAPK with a protein bearing a compatible amino acid motif that can be phosphorylated is sufficient for the functional regulation of the protein.

One implication of our results is that the evolution of new connections within MAPK regulation networks is only constrained by the two criteria discussed above---namely the appearance of 1) an accessible phospho-motif; and, 2) a protein-protein interaction strong enough to co-localize the new kinase-substrate pair. The proteomes of *Saccharomyces cerevisiae* and humans have \~3500 and \>50,000 phosphorylation sites, respectively ([@bib30], [@bib29]; [@bib7]). The amino acid composition of the surrounding phospho-motifs is constrained by the residues in and around the kinase active site; as such their length is generally fairly short---on the order of four amino acids on either side of the phosphorylated residue ([@bib74]). With such a short length, and given the degeneracy of the recognition requirements ([@bib46]), the probability that new phospho-motifs will appear by chance is high. Indeed, many human SNPs -- both those associated with disease as well as apparently healthy individual variation -- have been observed to create and destroy verified phospho-motifs ([@bib30]; [@bib57]; [@bib62]).

Many protein interactions occur between short, linear stretches of amino acids and protein domains, the classic examples being the PDZ and SH3 domains, but the binding of docking domains to the surfaces of MAPKs also belongs to this class ([@bib26]; [@bib43]; [@bib59]; [@bib75]). Like phospho-motifs, these short motifs can appear spontaneously during evolution ([@bib50]; [@bib18]; [@bib6]). Given that both phospho-motifs and short, linear interaction peptides are degenerate, common and short it is interesting to consider what constrains the formation of a new, functional connection between a kinase and a substrate---i.e. whether it is the formation of phospho-motifs or of protein-protein interactions that is rate limiting. This may be addressed by future studies.

Our creation of modular components for kinase signaling may help recapitulate the success modular transcriptional circuits have enjoyed ([@bib70]; [@bib37]; [@bib81]; [@bib55]). However, while our approach is a powerful tool it does have certain limitations. For instance, our system requires that a phosphodegron be known, and its cognate F-box be expressed for ubiquitination to occur. We demonstrate one way in which this problem may be addressed, i.e. by the design of new phosphodegrons based on the consensus sequences of the MAPK and F-box. Another consideration in any protein-engineering endeavor is the effect that various protein fusions have on expression---indeed we noted in our experiments that fusion of additional domains to MAPKs or their substrates altered the expression levels. These altered expression levels affect the behavior of kinase cascades, and so a sufficiently diverse set of modules need to be defined and characterized to make the desired behavior(s) achievable. Thus, the scalability afforded by the use of modular interaction domains comes at the potential price of altered protein expression. In contrast, using docking domains for co-localization obviates engineering the kinase, but is not a scalable rewiring approach. Finally, more work is necessary to render other kinase families 'engineerable'. Still the flexibility and scalability of kinase-substrate interactions demonstrated through our work lays a comprehensive foundation for future attempts to understand and re-engineer the signaling behavior of cells.

Materials and methods {#s4}
=====================

Strain construction {#s4-1}
-------------------

All strains were built using a W303a background into which each synthetic construct was integrated at either the URA, HIS, TRP or LEU genomic loci. The plasmids used to generate the strains are listed in [Supplementary file 1](#SD1-data){ref-type="supplementary-material"}. The YFP reporter constructs were built by fusing an SV40 nuclear localization tag, an interaction domain and a phosphodegron in tandem to the YFP protein separated by 12 amino acid long glycine-serine linkers. The retargeted kinase constructs were built by fusing a complementary interaction domain to the kinase, also separated by a 12 amino acid glycine-serine linker. The strong constitutive promoter derived from the native TDH3 gene was used to drive expression of the constructs. For all examples of the system that involved the yeast mating cascade, the kinase used was the MAPK *FUS3*. For the system that demonstrated mammalian MAPK retargeting, the kinase utilized was a constitutively active version of MEK1 fused to ERK2 and an interaction domain. For the feedback and feed-forward strains YFP was fused in tandem with the FUS1 gene, whose expression was activated by the mating pathway, to act as a reporter. These strains also had a copy of *FUS3* fused to an interaction domain integrated into the genome. In the case of the negative feedback and the feed-forward strains the genomic copies of Ste5, Ste7 and Ste12 were fused to an interaction domain, a phosphodegron and an mCherry reporter. The incoherent feed-forward strains were identical except that the expression of the YFP-nuclear localization tag-phosphodegron-interaction domain fusion was driven from a FUS1 promoter.

Cytometry {#s4-2}
---------

All cytometry measurements in experiments just measuring YFP expression were acquired with an Accuri C6 cytometer with attached CSampler apparatus using 488 nm and 640 nm excitation lasers and a 533 nm (FL-1: YFP/GFP) emission filter (BD Biosciences). In those experiments that included mCherry, we used a MACSQuant VYB (Miltenyi Biotec), with 405, 488 and 561 nm excitation lasers and 561 nm (FSC), 525 nm (YFP) and 615 nm (mCherry) emission filters. Synthetic complete growth medium was used in all experiments. Experiments involving time course data were taken during log phase via the following preparation: 16 hrs of overnight growth in the synthetic complete medium in a 30°C shaker incubator followed by 1:100 dilution into fresh, room-temperature medium. After 5 hrs of growth at 30°C, 100 µL aliquots were read periodically -- with 10 thousand events collected for every read -- until the completion of the experiment. In all cases where Fus3 was being retargeted, the yeast cultures were induced with α-factor 5 hrs post-dilution. For experiments involving dose response behavior, cultures were grown overnight, then diluted down in the morning 1:100 in fresh media and grown for 5 hrs to log phase. They were then induced with α-factor, as well as other inducers like ABA in some cases, and allowed to grow for between two to six hours depending on the experiment and then read on the cytometer. As the MEK-ERK2 fusion is constitutively active no inducer was necessary ([@bib60]).

Cytometry data analysis {#s4-3}
-----------------------

Data were analyzed using custom python scripts and FCSParser and Seaborn libraries (DOI: 10.5281/zenodo.45133) using the following steps: (1) Anomalies -- such as bubbles -- were identified by plotting and visually inspecting the FSC-A value versus the time each cell was collected for each well. (2) To prevent the creation of NA values when the data was log transformed any 0 values in the data collected from the Accuri C6 cytometer were converted to 1. Since data collected on the MACSQuant VYB can fall below 0, all the data was normalized by adding the absolute value of the lowest value collected that day to the raw values and then adding 1. (3) To control for the effects of cells size, the fluorescence values for each event were then divided by the FSC-A value for that event. All reported data is the aggregate of at least two technical replicates performed on consecutive days. The fits presented in [Figures 6](#fig6){ref-type="fig"} and [7](#fig7){ref-type="fig"} were performed using custom python scripts.

Degradation assays {#s4-4}
------------------

10 mL cultures of yeast strains expressing untargeted control substrates or targeted test substrates were grown at 30°C in YEPD medium to approximately 1\*10^7^ cells/mL. Cells were incubated with DMSO or the proteasome inhibitor MG132 (25 µg/mL) for 30 min prior to addition of α-factor or vehicle control for an additional 10 min. Cycloheximide was then added to a concentration of 50 µg/mL and cells were harvested by centrifugation at the denoted time points. Pellets were lysed in 200 µL SUMEB buffer (8 M urea, 10 mM MOPS, 10 mM EDTA, 1% SDS, 0.01% bromo- phenol blue, pH 6.8) by vortexing with acid washed beads for 5 min at 25°C. Lysate was clarified by centrifugation at 13000 rpm for 5 min and subjected to western analysis.

Western analyses {#s4-5}
----------------

Protein lysates were resolved by SDS-PAGE using 4--20% gradient gels (Lonza). Western analyses were performed with rabbit anti-GFP (1:2500) or mouse anti-ubiquitin antiserum (1:10).
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An analytical model for the incoherent feed-forward lLoop {#s17}
=========================================================

[@bib41] initially classified the different types of feedforward loop architectures and pointed out that Type 3 IFFLs can robustly generate pulses in gene expression. Here, we present a simple analytical model of the specific type 3 IFFL introduced in the main text, following an approach outlined by [@bib67]. The purpose of this model is to provide an intuition for the origin of the bandpass behavior that we observed in our experiments, rather than to give a detailed mechanistic study of the actual signaling cascade. We only consider three species in our model, namely Fus3, Ste12 and GFP. Fus3 is activated (indirectly) by α-factor and phosphorylates Ste12. Phosphorylated Ste12 acts as a transcriptional activator for GFP. Through a synthetic interaction Fus3 also directly phosphorylates the Tec1 phosphodegron fused to GFP, triggering the degradation of GFP.

For both Ste12 and Fus3 we only explicitly model the phosphorylated, active form. We use saturating functions to describe the phosphorylation and hence activation of Fus3 by α-factor and of Ste12 by Fus3. A similar function is used to model the production of GFP in response to Ste12. Degradation of GFP can be due to the interaction with Fus3 or due to other causes and the two processes are modeled independently. The full model is given by:$$\frac{d}{dt}\left\lbrack Fus3 \right\rbrack = \beta_{3}\frac{\lbrack\alpha\rbrack}{K_{\alpha} + \lbrack\alpha\rbrack} - \gamma_{3}\lbrack Fus3\rbrack,$$$$\frac{d}{dt}\left\lbrack Ste12 \right\rbrack = \beta_{12}\frac{\lbrack Fus3\rbrack}{K_{3} + \lbrack Fus3\rbrack} - \gamma_{12}\lbrack Ste12\rbrack,$$$$\frac{d}{dt}\left\lbrack GFP \right\rbrack = \beta_{GFP}\frac{\lbrack Ste12\rbrack}{K_{12} + \lbrack Ste12\rbrack} - \gamma_{GFP}\lbrack GFP\rbrack - \Gamma\lbrack Fus3\rbrack\lbrack GFP\rbrack.$$

Here, $\beta_{3}$, $\beta_{12}$ and $\beta_{GFP}$ are the maximal production rates while, $\gamma_{3}$, $\gamma_{12}$ and $\gamma_{GFP}$ are degradation rates. The paramter $\Gamma$ measures the strength of the Fus3-mediated degradation. If we assume that the system is in steady state we obtain three coupled equations for the three variables:$$\left\lbrack Fus3 \right\rbrack_{ss} = \lbrack Fus3\rbrack_{0}\frac{\lbrack\alpha\rbrack}{K_{\alpha} + \lbrack\alpha\rbrack},$$$$\left\lbrack Ste12 \right\rbrack_{ss} = \lbrack Ste12\rbrack_{0}\frac{\lbrack Fus3\rbrack}{K_{3} + \lbrack Fus3\rbrack},$$$$\left\lbrack GFP \right\rbrack_{ss} = \frac{\lbrack GFP\rbrack_{0}}{1 + \frac{\Gamma\lbrack Fus3\rbrack_{ss}}{\gamma_{GFP}}}\frac{\lbrack Ste12\rbrack_{ss}}{K_{12} + \lbrack Ste12\rbrack_{ss}}.$$

We can combine these equations to obtain the steady state value of GFP as a function of $\alpha$ factor:$$\left\lbrack GFP \right\rbrack_{ss} = \underset{F(\alpha)}{\underbrace{\lbrack GFP\rbrack_{0}\frac{\lbrack Ste12\rbrack_{0}\lbrack Fus3\rbrack_{0}}{K_{3}K_{12}}\frac{\lbrack\alpha\rbrack}{K_{\alpha} + \lbrack\alpha\rbrack\left( 1 + \frac{\lbrack Fus3\rbrack_{0}}{K_{3}} + \frac{\lbrack Ste12\rbrack_{0}\lbrack Fus3\rbrack_{0}}{K_{3}K_{12}} \right)}}}\underset{G(\alpha)}{\underbrace{\frac{K_{\alpha} + \lbrack\alpha\rbrack}{K_{\alpha} + \lbrack\alpha\rbrack\left( 1 + \frac{\Gamma\lbrack Fus3\rbrack_{0}}{\gamma_{GFP}} \right)}}}.$$

$F{(\alpha)}$ is the steady state level of GFP that would be observed in a linear cascade without the repressive link from Fus3 to GFP (i.e. the system of [Figure 7A](#fig7){ref-type="fig"}). This function monotonously increases with increasing $\alpha$-factor concentration. $G{(\alpha)}$ captures the impact of degradation of Fus3 due to GFP.

The steady state level of GFP is thus of the general form$${\left\lbrack {GFP} \right\rbrack_{ss} = {B\frac{\lbrack\alpha\rbrack}{1 + {C{\lbrack\alpha\rbrack}}}\frac{1 + {E{\lbrack\alpha\rbrack}}}{1 + {D{\lbrack\alpha\rbrack}}}}},$$

where the values of the constants $B$-$E$ can be derived from [Equation 7](#equ7){ref-type="disp-formula"}. This function tends to zero for vanishing $\lbrack\alpha\rbrack$ and asympotically reaches the value $BE/(CD)$ for ${\lbrack\alpha\rbrack} \gg 1$. We note that the saturation at a non-zero value is consistent with our experimental observations ([Figure 7B](#fig7){ref-type="fig"}). Moreover, by taking the derivative it can also be shown that this expression has a maximum at an intermediate value of $\lbrack\alpha\rbrack$, consistent with the observed band-pass behavior.

Data fitting {#s18}
============

To fit our data we used a slightly more general expression where we allow for leaky production of GFP (paramter $A$) and also allow for a non-linearity in the cascade (Hill coefficient $n > 1$):$${{\lbrack{GFP}\rbrack}_{ss} = {A + {B\frac{{\lbrack\alpha\rbrack}^{n}}{1 + {C{\lbrack\alpha\rbrack}^{n}}}\frac{1 + {E{\lbrack\alpha\rbrack}}}{1 + {D{\lbrack\alpha\rbrack}}}}}}.$$

Parameters $A$, $B$, $C$, and $n$ are all shared between the data shown in [Figure 7A](#fig7){ref-type="fig"} (linear cascade) and [Figure 7B](#fig7){ref-type="fig"}. Parameter values used for the fits are $A$ = 1.1, $B$ = 8.6, $C$ = 0.8, $D$ = 9.9, $E$ = 0.2 and $n$ = 2.5.
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Thank you for submitting your article \"Rewiring MAP kinases in *Saccharomyces cerevisiae* to regulate novel targets through ubiquitination\" for consideration by *eLife*. Your article has been reviewed by two peer reviewers, and the evaluation has been overseen by Ivan Dikic as the Senior and Reviewing Editor.

The reviewers have discussed the reviews with one another and the Reviewing Editor has drafted this decision to help you prepare a revised submission.

Summary:

The ability to rationally engineer post-translational circuits utilizing processes like phosphorylation and ubiquitylation is critical for expanding synthetic biology beyond transcriptional circuitry. Here, the authors developed a new technique based on target phosphorylation motifs and protein interaction domains to engineer post-translational interactions between MAPK kinases and protein substrates. Using engineered pathways in yeast where a MAP kinase (Fus3 or Erk2) is targeted to artificial substrate protein through fusion of both the kinase and substrate to compatible interaction domains, they determine that this mode of interaction and the presence of the cognate phosphorylation motif (in this case a phosphodegron) is sufficient to confer MAPK regulation of the substrate (in this case leading to degradation). They used this technique to control ubiquitin-dependent degradation of fluorescent reporters (such as YFP) and to rewire signaling circuits in yeast both transcriptionally and post-translationally. The key findings include: 1) substrate phosphorylation by a MAPK kinase can be engineered in a highly modular fashion by combining two distinct modules (protein-protein interaction and phosphorylation motif); 2) the engineered phosphorylation can enable new signaling capabilities through feedback/feedforward loops. The technique is novel and is useful for dissecting natural signaling pathways as well as for synthesizing new signaling behaviors. In particular, it represents an exciting example of engineering a fully post-translational feedback loop in a signaling system, which makes this a major step forward from a synthetic biology point of view. The manuscript could be strengthened by consideration (and integration) of known mechanisms for docking interactions involving Fus3, and their role in regulating signal output (Remenyi et al. Mol Cell 2005).

Essential revisions:

1\) Protein-protein interaction domains. The paper focused on exploring both natural and synthetic interaction domains, including PDZ, SH3, SYNZIP. In their approach, two interaction domains are fused separately to the MAPK kinase and the non-native protein substrate. Thus, both proteins need to be engineered to enable the phosphorylation interaction. In contrast to this approach (and as the authors citied), an alternative approach is to only engineer the protein substrate by utilizing native docking interactions between MAPK kinase and its substrate. Regot et al. and Durandau et al. used this alternative strategy to control fluorescent reporter localization. Can the authors comment on the relative capabilities of these different design strategies?

2\) Related to point 1. In the current design, the ligand is fused to the kinase and the corresponding binding domain is fused to the substrate. What if the locations of the two domains are swapped? If the response is not sensitive to where the domain is fused, then it will provide stronger support to the claim that the design is highly modular. If the authors have data on this already, it would be helpful to report it because, even if the result is negative, it would be useful for other researchers seeking to design similar systems.

3\) Additional controls, some biochemical in nature, should be provided to confirm that regulation is via the proposed mechanism. Kinase dead Fus3 should be included in certain key experiments (e.g. [Figure 1](#fig1){ref-type="fig"}) to confirm that phosphorylation of the substrate is actually mediated by the Fus3 kinase fusion. The authors should also confirm that degradation of the YFP-degron construct is mediated via the SCF complex and ubiquitin-mediated proteasomal degradation. The experiments describing implementation of negative feedback and feedforward topologies require the inclusion of dynamic, time-course data. Temporal regulation of signal output could be markedly different when MAPK is targeted to phosphorylate alternative network components.

4\) Scalability of the design. In [Figure 2D-E](#fig2){ref-type="fig"}, the authors used different interaction domains to control the phosphorylation of two different substrates by Fus3. However, the response of the YFP substrate is much weaker than that of the mCherry substrate. First, what about the response in individual cells? Is the response of YFP always weaker than mCherry in all individual cells, or only in subpopulations? Second, is this due to the saturation of the system? If so, it would be helpful to identify the source of limitation that can be improved in the future.

10.7554/eLife.15200.023

Author response

*Essential revisions:*

*1) Protein-protein interaction domains. The paper focused on exploring both natural and synthetic interaction domains, including PDZ, SH3, SYNZIP. In their approach, two interaction domains are fused separately to the MAPK kinase and the non-native protein substrate. Thus, both proteins need to be engineered to enable the phosphorylation interaction. In contrast to this approach (and as the authors citied), an alternative approach is to only engineer the protein substrate by utilizing native docking interactions between MAPK kinase and its substrate. Regot et al. and Durandau et al. used this alternative strategy to control fluorescent reporter localization. Can the authors comment on the relative capabilities of these different design strategies?*

We agree that this is an important point to emphasize, and we have more specifically contrasted the advantages of our strategy and those of Regot et al. and Durandau et al. in the introduction with the addition of this paragraph:

"Targeting a kinase to a new substrate is an essential step towards creating modular kinase signaling systems. As discussed above, Regot et al. and Durandau et al. have described an approach wherein a kinase-specific docking domain can be used to direct a particular kinase to a new substrate---a powerful tool for interrogating natural kinase signaling systems. However, the number of naturally occurring kinase-substrate docking interactions inherently limits the scalability of the approach. For example, a given kinase 'module' cannot be reused in parallel signaling pathways, because it would not be able to distinguish between downstream targets in 2 one pathway versus another. To overcome this limitation, it would be useful to be able to tease apart the 'targeting' module of the kinase from the 'enzymatic' module---and likewise, the 'targeting' and 'effector' modules of the substrate. If these functions can be defined as separable parts, the enzymatic module of a kinase would be available for reuse in orthogonal pathways, just by pairing it with unique targeting domains."

We have also added the following sentence to the final paragraph of the discussion, to further highlight the benefits and limitations of both approaches:

"Thus, the scalability afforded by the use of modular interaction domains comes at the potential price of altered protein expression. In contrast, using docking domains for co-localization obviates engineering the kinase, but is not a scalable rewiring approach."

*2) Related to point 1. In the current design, the ligand is fused to the kinase and the corresponding binding domain is fused to the substrate. What if the locations of the two domains are swapped? If the response is not sensitive to where the domain is fused, then it will provide stronger support to the claim that the design is highly modular. If the authors have data on this already, it would be helpful to report it because, even if the result is negative, it would be useful for other researchers seeking to design similar systems.*

On the advice of the reviewers we constructed and tested a system where the interaction domains fused to the kinase and substrate were exchanged. Specifically, we swapped the mPDZ domain from the substrate to the kinase and the PDZ ligand from the kinase to the substrate -- the results can be found in [Figure 1---figure supplement 3](#fig1s3){ref-type="fig"}. The two orientations exhibited the same qualitative behaviors, however the maximal fold change observed for the swapped domains was approximately half that of the original orientation. These qualitative similarities -- and quantitative differences -- are consistent with our experiences with the other targeting domain pairs ([Figure 2](#fig2){ref-type="fig"}). As we have discussed in the manuscript, these differences are likely due the fusions affecting either protein expression or sterically interfering with the function of one of the involved enzymes. Thus, while these domains and their functions appear to be largely modular, it is not entirely cut and dry.

*3) Additional controls, some biochemical in nature, should be provided to confirm that regulation is via the proposed mechanism. Kinase dead Fus3 should be included in certain key experiments (e.g. [Figure 1](#fig1){ref-type="fig"}) to confirm that phosphorylation of the substrate is actually mediated by the Fus3 kinase fusion. The authors should also confirm that degradation of the YFP-degron construct is mediated via the SCF complex and ubiquitin-mediated proteasomal degradation.*

We agree that testing a kinase dead version of Fus3 is a thoughtful control, and that it would help demonstrate whether Fus3 kinase activity is necessary. We have performed the experiments described in [Figure 1](#fig1){ref-type="fig"} again, this time with the addition of a strain expressing an inactive version of Fus3.

To provide the further biochemical evidence that the decrease of the YFP signal is mediated via proteasomal degradation, we have tested the protein level of the YFP-degron construct in the absence and the presence of the proteosomal inhibitor MG132 ([Figure 1---figure supplement 2](#fig1s2){ref-type="fig"}). The level of the YFP-degron fusion protein only decreases in cells treated with α-factor, not in cells treated 3 with both α-factor and MG132, indicating that normal proteasome function is critical for the turnover of the YFP signal.

*The experiments describing implementation of negative feedback and feedforward topologies require the inclusion of dynamic, time-course data. Temporal regulation of signal output could be markedly different when MAPK is targeted to phosphorylate alternative network components.*

On the reviewers' advice, we have included time course data for both the negative feedback and the feed-forward topologies in [Figure 6---figure supplement 1](#fig6s1){ref-type="fig"}.

*4) Scalability of the design. In [Figure 2D-E](#fig2){ref-type="fig"}, the authors used different interaction domains to control the phosphorylation of two different substrates by Fus3. However, the response of the YFP substrate is much weaker than that of the mCherry substrate. First, what about the response in individual cells? Is the response of YFP always weaker than mCherry in all individual cells, or only in subpopulations? Second, is this due to the saturation of the system? If so, it would be helpful to identify the source of limitation that can be improved in the future.*

We appreciate the reviewers' concerns regarding the possibility that subpopulations of cells might be responding to the input signal in very different fashions. In fact, this is actually a concern throughout all of the experiments. For this reason we have recast all of our data to more clearly communicate the response across the entire population -- instead of reporting the mean and standard deviations between separate experiments, the data now appear either as histograms or as the medians and quartiles of the populations. In all cases, the entire population appears to respond to the input -- as opposed to a subset, which would result in a bimodal distribution, etc.

As suggested by the reviewers, we have performed experiments to determine whether a particular step in the system was limiting, and as a result caused the disparity between the degradation of mCherry and YFP shown in [Figure 2D-E](#fig2){ref-type="fig"}. There are two points where components of our system might compete for limiting resources. Since the two copies of Fus3 are overexpressed, they may compete for access to the endogenously expressed upstream MAPKK, Ste7. Likewise, the YFP and mCherry substrates might compete for access to the ubiquitin/proteasomal machinery. To test this we constructed strains that expressed our standard system -- one kinase targeting one substrate -- and added either a competing copy of Fus3 or a competing substrate ([Figure 3---figure supplements 1](#fig3s1){ref-type="fig"} and [2](#fig3s2){ref-type="fig"}). In both experiments we observed a diminished response in YFP degradation in the presence of the competitor. It should also be noted that the ABA-inducible interaction domains elicit a weaker degradation response compared to the mPDZ-PDZ ligand interaction (compare data in [Figure 2B and C](#fig2){ref-type="fig"}). Thus, it is likely that a confluence of all these factors -- saturation points as well as the less efficient ABA-induced interaction -- contribute to the different levels of degradation observed for the mCherry and YFP reporters in this dual-targeting system.

[^1]: These authors contributed equally to this work.
